國家衛生研究院 NHRI:Item 3990099045/2982
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 856741      Online Users : 866
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2982


    Title: Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts
    Other Titles: Therapeutic efficacy evaluation of (111)in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts
    Authors: Lee, WC;Hwang, JJ;Tseng, YL;Wang, HE;Chang, YF;Lu, YC;Ting, G;Whang-Peng, J;Wang, SJ
    Contributors: National Institute of Cancer Research
    Abstract: The purpose of this study is to evaluate the therapeutic efficacy of the liposome encaged with vinorelbine (VNB) and In-111-oxine on human colorectal adenocarcinoma (HT-29) using HT-29/luc mouse xenografts. HT-29 cells stably transfected with plasmid vectors containing luciferase gene (luc) were transplanted subcutaneously into the male NOD/SCD mice. Biodistribution of the drug was performed when tumor size reached 500-600 mm(3). The uptakes of In-111-VNB-liposome in tumor and normal tissues/organs at various time points postinjection were assayed. Multimodalities, including gamma scintigraphy, bioluminescence imaging (BLI) and whole-body autoradiography (WBAR), were applied for evaluating the therapeutic efficacy when tumor size was about 100 mm(3). The tumor/blood ratios of In-111-VNB-liposome were 0.044, 0.058, 2.690, 20.628 and 24.327, respectively, at 1, 4, 24, 48 and 72h postinjection. Gamma scinitigraphy showed that the tumor/muscle ratios were 2.04, 2.25 and 4.39, respectively, at 0, 5 and 10 mg/kg VNB. BLI showed that significant tumor control was achieved in the group of 10 mg/kg VNB (In-111-VNB-liposome). WBAR also confirmed this result. In this study, we have demonstrated a non-invasive imaging technique with a luciferase reporter gene and BLI for evaluation of tumor treatment efficacy in vivo. The SCID mice bearing HT-29/luc xenografts treated with In-111-VNB-liposome were shown with tumor reduction by this technique.
    Keywords: Instruments & Instrumentation;Nuclear Science & Technology;Physics, Particles & Fields;Spectroscopy
    Date: 2006-12-20
    Relation: Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2006 Dec;569(2):497-504.
    Link to: http://dx.doi.org/10.1016/j.nima.2006.08.135
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0168-9002&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000243241300076
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33751430072
    Appears in Collections:[Jacqueline Whang-Peng(1996-2007)] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    000243241300076.pdf945KbAdobe PDF1125View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback